Parallel Advisors, LLC Solid Biosciences Inc. Transaction History

Parallel Advisors, LLC

  • $3.67 Billion
  • Q1 2024

A detailed history of Parallel Advisors, LLC transactions in Solid Biosciences Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 6 shares of SLDB stock, worth $35. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6
Previous 6 -0.0%
Holding current value
$35
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023
SELL
$5.27 - $6.86 $495 - $644
-94 Reduced 94.0%
6 $0
Q1 2022

Apr 28, 2022
BUY
$0.74 - $1.79 $74 - $179
100 New
100 $0
Q4 2021

Jan 20, 2022
SELL
$1.69 - $2.46 $491 - $715
-291 Closed
0 $0
Q3 2021

Nov 02, 2021
BUY
$2.38 - $3.77 $692 - $1,097
291 New
291 $1,000

Others Institutions Holding SLDB

# of Institutions
2
Shares Held
96
Call Options Held
0
Put Options Held
0
View Full List

About Solid Biosciences Inc.

SLDB Quotes by TradingView
  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $44.9M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email